Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, 2001 Inwood Road, Dallas, TX, 75390, USA.
Department of Dermatology, UT Southwestern Medical Center, Dallas, TX, USA.
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):335-341. doi: 10.1007/s00405-021-06763-z. Epub 2021 May 6.
The prognostic significance of auricular location in cutaneous squamous cell carcinoma (cSCC) is controversial. We aimed to characterize risk factors for, and evaluate the cumulative incidence of, locoregional recurrence in a cohort of patients with primary auricular cSCC.
The study design was a single-institution retrospective cohort review from 1/2007 to 12/2016.
Among 851 potentially eligible individuals, 178 patients with primary auricular cSCC met strict criteria for inclusion. Median follow-up was 32 months, 93% were AJCC 8th edition (AJCC8) stage I and 6% were AJCC8 stage II. Most underwent Mohs micrographic surgery (MMS; 97%) and the remainder underwent wide local excision ± parotidectomy ± neck dissection ± adjuvant therapy (3%). Recurrences occurred in seven patients (4%): six were local and one was regional. The 3-year cumulative incidence of local and regional recurrence for AJCC8 stage I-II tumors were 1% (95% CI 0-5%) and 0%, respectively. Among ten patients upstaged to pT3 disease who underwent MMS alone, none recurred locoregionally. Compared to their respective counterparts, advanced stage, PNI, and LVI associated with a significantly increased risk of locoregional recurrence.
Our findings suggest that auricular location may not be a significant risk factor for cSCC staging systems. In the absence of other risk factors, unimodal therapy appears adequate for patients with primary, stage I-II auricular cSCC. The prognostic significance of pT3 auricular cSCC stage due to depth of invasion alone should be evaluated further.
耳廓部位在皮肤鳞状细胞癌(cSCC)中的预后意义尚存在争议。本研究旨在对一组原发性耳廓 cSCC 患者的局部区域复发的危险因素进行分析,并评估其累积发生率。
该研究为 2007 年 1 月至 2016 年 12 月的单机构回顾性队列研究。
在 851 名可能符合条件的患者中,178 名患有原发性耳廓 cSCC 的患者符合严格的纳入标准。中位随访时间为 32 个月,93%为 AJCC 第 8 版(AJCC8)Ⅰ期,6%为 AJCC8 Ⅱ期。大多数患者接受 Mohs 显微外科手术(MMS;97%),其余患者接受广泛局部切除+/-腮腺切除术+/-颈淋巴结清扫术+/-辅助治疗(3%)。7 例患者(4%)发生复发:6 例为局部复发,1 例为区域复发。AJCC8 Ⅰ-Ⅱ期肿瘤的 3 年局部和区域复发累积发生率分别为 1%(95%CI 0-5%)和 0%。在 10 例因 pT3 疾病而升级为 pT3 疾病并单独接受 MMS 治疗的患者中,无局部区域复发。与各自的对照组相比,晚期、PNI 和 LVI 与局部区域复发风险显著增加相关。
我们的研究结果表明,耳廓位置可能不是 cSCC 分期系统的重要危险因素。在没有其他危险因素的情况下,单一模式治疗似乎足以治疗原发性、Ⅰ-Ⅱ期耳廓 cSCC 患者。由于单纯浸润深度而导致的 pT3 期耳廓 cSCC 分期的预后意义应进一步评估。